Yayıncı "Pergamon-Elsevier Science Ltd" Eğitim ve Araştırma Hastanesi Koleksiyonu için listeleme
Toplam kayıt 4, listelenen: 1-4
-
EFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSIS
(Pergamon-Elsevier Science Ltd, 2017) -
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study
(Pergamon-Elsevier Science Ltd, 2018)Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular ... -
Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
(Pergamon-Elsevier Science Ltd, 2018) -
The role of ETS-1 transcription factor in the pathogenesis of chronic lymphocytic leukemia
(Pergamon-Elsevier Science Ltd, 2019)